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ABSTRACT 
Biologic scaffolds are derived from mammalian tissues, which must be decellularized to remove 
cellular antigens that would otherwise incite an adverse immune response. Although widely used 
clinically, the optimum balance between cell removal and the disruption of matrix architecture and 
surface ligand landscape remains a considerable challenge. Here we describe the use of time of flight 
secondary ion mass spectroscopy (ToF-SIMS) to provide sensitive, molecular specific, localized analysis 
of detergent decellularized biologic scaffolds.  We detected residual detergent fragments, specifically 
from Triton X-100, sodium deoxycholate and sodium dodecyl sulphate (SDS) in decellularized 
scaffolds; increased SDS concentrations from 0.1% to 1.0% increased both the intensity of SDS 
fragments and adverse cell outcomes. We also identified cellular remnants, by detecting phosphate 
and phosphocholine ions in PAA and CHAPS decellularized scaffolds.  The present study demonstrates 
ToF-SIMS is not only a powerful tool for characterization of biologic scaffold surface molecular 
functionality, but also enables sensitive assessment of decellularization efficacy.  
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STATEMENT OF SIGNIFICANCE  
We report here on the use of a highly sensitive analytical technique, time of flight secondary ion mass 
spectroscopy (ToF-SIMS) to characterize detergent decellularized scaffolds.  ToF-SIMS detected 
cellular remnants and residual detergent fragments; increased intensity of the detergent fragments 
correlated with adverse cell matrix interactions. This study demonstrates the importance of 
maintaining a balance between cell removal and detergent disruption of matrix architecture and 
matrix surface ligand landscape.  This study also demonstrates the power of ToF-SIMS for the 
characterization of decellularized scaffolds and capability for assessment of decellularization efficacy. 
Future use of biologic scaffolds in clinical tissue reconstruction will benefit from the fundamental 
results described in this work.   
  
1. INTRODUCTION  
The resident cells of each tissue or organ secrete and maintain an extracellular matrix (ECM) which 
consists of structural and functional molecules. Interactions between tissue resident cells and the 
surrounding ECM constitute a state of ‘dynamic reciprocity’ [1, 2] whereby the ECM provides both 
structural support and signalling molecules that influence cell behaviour and the local cell populations 
respond by modifying the ultrastructure and composition of the ECM. Stated differently, the ECM 
provides tissue-specific molecular and mechanical cues that contribute to the maintenance of cellular 
homeostasis, promote optimal tissue function and if required, mediate wound healing and tissue 
repair [3]. Biologic scaffolds composed of ECM are widely used for a variety of clinical applications 
including breast reconstruction [4, 5], ventral hernia repairs [6, 7], esophageal reconstruction [8, 9], 
and the replacement of functional skeletal muscle following severe traumatic injury [10, 11], among 
others [12, 13].  Such biologic scaffolds are prepared by decellularization of tissues and organs to 
remove cellular antigens capable of inducing an adverse immune response. The objective of any 
decellularization process is to completely isolate and preserve the extracellular matrix components 
and structure within a tissue whilst removing all cellular components [14]. In reality, this is an 
impossible feat as all decellularization methods disrupt ECM ultrastructure and composition through 
the processes that damage and remove cells and cell debris from tissues. Similarly, complete removal 
of all cell remnants is not possible and a balance must be achieved between cell removal and the 
disruption of matrix architecture, and matrix surface ligand landscape.  
 
Preferred methods of decellularization vary amongst tissues and organs due to tissue-specific factors 
such as tissue size, thickness and shape, and cell and matrix density considerations. One of the most 
common techniques is immersion in a detergent solution with mechanical agitation to solubilize cell 
membranes and dissociate DNA and other cellular contents. Detergents have been used to 
decellularize multiple tissues and organs including tendon [15], esophagus [16, 17], trachea [18, 19], 
peripheral nerve [20], spinal cord [21, 22], heart valves [23] and dermis [24]. Recently, detergents have 
been applied in perfusion of whole organs with success in retrograde coronary perfusion in rat [25] 
and porcine [26] hearts, vascular perfusion in lungs [27] and perfusion via the portal vein in liver [28, 
29]. Detergents for decellularization are typically non-ionic, ionic or zwitterionic. Non-ionic 
detergents, e.g. Triton X-100, disrupt DNA-protein, lipid-lipid and lipid-protein interactions [30] whilst 
maintaining native protein structures. Ionic detergents, e.g. sodium dodecyl sulfate (SDS) and sodium 
deoxycholate, completely solubilize cell and nucleic membranes and fully denature proteins [31]. 
Zwitterionic detergents, e.g. 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS) 
have a net zero electrical charge on the hydrophilic head groups which protects the native state of 
proteins during decellularization and exhibit properties of both ionic and non-ionic detergents [30]. It 
is logical and expected that use of such detergents will have some disruptive effect upon the ECM 
during the process of decellularization. 
 
Time of flight secondary ion mass spectrometry (ToF-SIMS) is an analytically sensitive, information-
rich surface analytical technique that has been used to investigate various biological samples, from 
the distribution of proteins and lipids in brain tissue [32] to high throughput screening of polymer 
microarrays as cell substrates [33-35]. Recently, ToF-SIMS was utilized to identify differences in cell-
secreted matrices [36], to confirm adsorption of complex extracellular matrix coatings [37] and to 
analyse variances in the surface composition of decellularized tissues from different origins [38, 39]. 
In ToF-SIMS the surface of interest is bombarded by a primary ion beam (in this study Bi3+) which gives 
rise to characteristic fragments from the top few nanometers of the surface [36]. A proportion of the 
fragments emitted are charged ions (positive and negative) which may be analysed using a time of 
flight detector to provide mass/charge spectra characteristic of the surface. Analysis of the spectra 
provides further information on the chemical moieties, structure and molecular orientation of the 
surface [40]. During ToF-SIMS analysis, macromolecules on the sample surface are fragmented which 
often results in spectra containing multiple low mass peaks, rather than individual peaks characteristic 
of a single component [40]. Translating these low mass peaks into chemical information is challenging. 
 
ToF-SIMS characterization of decellularized ECM scaffolds is particularly challenging due to the 
chemical and structural complexity of the scaffold surface. Multiple spectra are taken per sample with 
each spectrum representing a detailed molecular map of the surface. Since the scaffold surface 
provides the first contact for cells during in vitro culture or upon in-vivo implantation, analysis of the 
surface molecular chemistry will provide vital insight into the effect of detergent based 
decellularization. With the availability of ToF-SIMS to probe surface characteristics of materials, the 
present study aims to (i) use ToF-SIMS to identify differences in the composition of detergent 
decellularized biologic scaffolds using urinary bladder matrix as a suitable substrate; (ii) correlate 
these differences with the chemical structure of detergents; (iii) observe residual detergent left behind 
after the decellularization process and (iv) assess the effect of surface molecular functionality of the 
detergent decellularized scaffolds upon cell behaviour.  
 
2. METHODS 
2.1 Scaffold preparation and decellularization  
Porcine urinary bladders were obtained from market weight animals (Tissue Source, Lafayette IN). 
Bladders were frozen (>24 h at 80°C) and thawed completely before use. To prevent the presence of 
contaminants in ToF-SIMS analysis, all surfaces, tools and apparatus that came into contact with the 
bladders were washed in acetone (Fisher) and then methanol (Fisher) prior to use. The basement 
membrane complex (BMC) and underlying tunica lamina propria of the intact bladder tissue were 
isolated and harvested as previously described [38, 41, 42]. Briefly, excess connective tissue, adipose 
tissue and the apex were removed from the bladders using scissors. Bladders were rinsed under 
running water to remove residual urine and then bisected on one side from the neck to the dome to 
form a rectangular sheet. The luminal side of the bladder was placed downwards and the tunica 
serosa, tunica muscularis externa, tunica submucosa and tunica muscularis mucosa were removed by 
mechanical delamination leaving behind a biologic scaffold composed of intact BMC and tunica lamina 
propria. The isolated layers were cut into 6 pieces, squares of approximately 5 cm x 5 cm in size for 
detergent treatment. Samples were subjected to detergent treatments commonly used for 
decellularization comprising: 3% Triton X-100 (Sigma-Aldrich), 8mM CHAPS (Sigma-Aldrich), 4% 
sodium deoxycholate (Sigma-Aldrich), 1% sodium dodecyl sulfate (SDS) (Bio-Rad), 0.1% SDS (Bio-Rad) 
or deionized water for 24 h with physical agitation (orbital shaker at 300 rpm). These selected 
detergents and concentrations reflect common usage; detergent exposure times have been designed 
to be less than or equivalent to current experimental practices [15, 18, 19, 21, 31, 43]. An additional 
group of samples was subjected to 0.1 % peracetic acid (PAA) (Sigma-Aldrich) for 2h and then 
deionized water for 22 h with physical agitation (300 rpm on an orbital shaker). PAA treatment for 2h 
has previously been shown to be effective in dissociation of DNA and other cellular components [44]. 
With the exception of Triton X-100 which was adjusted to a pH of 11.4, all other detergents were 
utilized at their natural pH. After 24 h treatment, all scaffold groups were subjected to an extensive 
washing procedure, which was equivalent or exceeded that typically used in decellularization [31].  
Scaffolds were rinsed in deionized water for 15 minutes with agitation (300 rpm on orbital shaker). 
This rinse cycle was repeated three times, to provide a total of 4 x 15 minute deionized water washes. 
Each treatment group was then washed for 24 h in deionized water with agitation (300 rpm on orbital 
shaker). At the end of this wash cycle the 4 x 15 minute deionized water rinses were repeated and the 
bladders were then washed for a final 24 hours in deionized water. This extensive washing is 
equivalent to or exceeds that used commonly in decellularization. The decellularized bladder tissue 
represents urinary bladder matrix (UBM). The UBM samples were then frozen flat on film, prior to 
being lyophilized. 
 
2.2 Determination of decellularization efficacy   
Lyophilized scaffolds were hydrated prior to fixing in 10% neutral buffered formalin for 24 h. The fixed 
scaffolds were embedded in paraffin and cut into 5 μm sections onto slides.  Slides were stained with 
hematoxylin and eosin (H&E). Quantification of dsDNA occurred as previously described [45, 46]. 
Briefly, treated scaffolds were powdered with a Wiley Mill using a 60-mesh. Samples (100 mg) 
scaffolds were digested in 0.1 mg/ml proteinase K digestion buffer solution for 24 h at 50°C. DNA was 
extacted twice in phenol/chloroform/isoamyl alcohol and centrifuged at 10,000g for 10 min at 4°C. 
The top aqueous phase, containing the DNA, was mixed with 3M sodium acetate and 100% ethanol 
and frozen on dry ice for 20 minutes. Frozen samples were then centrifuged at 4°C for 10 min at 
10,000g. The supernatant was poured off and 70% ethanol added.  Centrifugation was repeated and 
the supernatant removed and remaining DNA pellet dried.  When dry, the resultant pellet was 
suspended in TE buffer (10mM Tris/1mM EDTA) and double stranded DNA was quantified in triplicate 
using Quant-iT PicoGreen Reagent (Invitrogen Corp., Carlsbad, CA, USA) according to the 
manufacturer’s instructions.  
 
2.3 Scanning electron microscopy 
Scanning electron microscopy (SEM) was used to examine the surface topology of urinary bladders 
treated with each detergent. Scaffolds were critical point dried using a Leica EM CPD030 Critical Point 
Dryer (Leica Microsystems, Buffalo Grove, IL, USA) with carbon dioxide as the transitional medium. 
Scaffolds were then sputter-coated with a 4.5 nm thick gold/palladium alloy coating using a Sputter 
Coater 108 Auto (Cressington Scientific Instruments, UK) and imaged with a JEOL JSM6330f scanning 
electron microscope (JEOL, Peabody, MA, USA). 
 
2.4 Preparation of detergent droplets  
ToF-SIMS analysis of detergent samples on inert wafers provided reference detergent spectra for UBM 
treated scaffolds. Ten cm diameter silicon wafers (Silicon Valley Microelectronics, CA) were scored 
and diced into 1 x 1 cm squares. Silicon squares were cleaned by sequential sonication in ultra-pure 
deionized water, dichloromethane, acetone and methanol, with two x 15 minute washes for each 
solvent and allowed to dry before use. 200 μl each of 3% Triton X-100, 8 mM CHAPS, 1% SDS, 4% 
Sodium deoxycholate and stock PAA (15%) was loaded onto the cleaned wafers and allowed to air dry.  
These detergent loaded wafers were then analysed using the ToF-SIMS conditions described below to 
provide reference spectra. During ToF-SIMS analysis, the presence of the tissue derived scaffold may 
alter the ionisation with subsequent fragment peaks observed, including protonated ions of the 
detergent residues. The characteristic peaks observed on the detergent wafers (reference spectra) 
were thus utilized in the identification of detergent residues on the UBM samples. 
 2.5 ToF-SIMS analysis 
Each treatment group consisted of individual samples from 5 different bladders. Three representative 
~1 cm x 1cm areas were cut from separate UBM samples taken from each treatment group and 
mounted to the top mount analysis plate using double-sided tape. Positive and negative ion spectra 
were obtained from the basement membrane side of samples using an ION-TOF V (ION-TOF GmbH) 
instrument with a 25 keV Bi3+ analysis beam mounted at 45° to the sample, with the extractor and 
flight tube normal to the sample. The primary ion current was 0.8 pA and the total ion dose was kept 
below 1012 ions cm-2 to ensure static SIMS conditions. An electron floodgun was used for charge 
compensation. The area of analysis was 100 x 100 µm, consisting of 128 x 128 pixels.  Positive and 
negative spectra were collected over the mass range of m/z 0 – 800. At least three replicates were 
prepared for each sample type, with at least three spectra obtained from separate sites on each 
replicate sample. Spectra exhibiting charging issues due to severe topography or very high salt (Na+) 
intensities were discarded. At least 10 spectra per treatment condition were retained in each polarity 
for further analysis. Positive ion spectra were calibrated against peaks for CH2+, CH3+, C3H2+ and C4H3+ 
before further analysis. Negative ion spectra were calibrated against peaks for C-, C2-, C3- and C4- before 
further analysis. Supplementary analysis of detergent drops, dried on silicon wafers, was performed 
in a similar fashion. 
 
 2.6 Principal component analysis 
Multivariate analysis techniques are mathematical methods that can be used to identify spectral 
differences and thus improve the specificity and sensitivity of data obtained from complex, 
multicomponent surfaces [47]. Principal component analysis (PCA) is a multivariate technique that has 
previously been used to distinguish spectra from lipids in cellular membranes [48], residual ECM 
proteins following cell lift off [49] and decellularized tissues [38, 39]. In PCA, a set of new variables 
called principal components (PCs) are calculated which represent new axes in the data space [47, 50] 
and bisect areas of variance within the original dataset. The largest percentage of variance between 
groups within the original dataset will be captured by the first PC. Each subsequent PC is orthogonal 
to the previous PC and captures sequentially less variance [39].  
 
PCA was performed using the spectragui package of the National ESCA and Surface Analysis Center for 
Biomedical Problems (NESAC/BIO) MVA Toolbox running in MATLAB R2012a (The MathWorks Inc). 
Peaks below m/z 500 were manually identified using SurfaceLab 6 (ION-TOF GmbH) and selected in 
overlaid spectra from each sample set, before adding to a peak list. Peak intensities were compiled 
into a single-tab separated text file which was then imported into spectragui. Spectra were normalized 
against the total ion intensity of the peak set and scaled by square-root mean centering before PCA 
was performed.  
 
2.7 Urothelial cell culture  
Lyophilized UBM sheets from each group were cut to 2 cm diameter circles with surgical scissors for 
use in cell growth studies and were sterilized with ethylene oxide (EtO) gas (16 h cycle at 50 °C in a 
Series 3plus EOGas Sterilizer, Anderson Sterilizers, Inc., Haw River, NC). Sterilized scaffolds were 
placed with the BMC luminal surface facing upwards in a 6-well plate. Human urothelial cells (HUCs; 
purchased from ScienCell, Carlsbad, CA) were cultured in urothelial cell medium (UCM; ScienCell, 
Carlsbad, CA) containing 1% urothelial growth supplement (ScienCell, Carlsbad, CA) and 1% 
penicillin/streptomycin solution (ScienCell, Carlsbad, CA). HUCs were cultured in poly-L-lysine coated 
culture vessels (2 µg/cm2) at 37°C and 5% CO2 and media was changed every other day.  After allowing 
the cells to propagate to sufficient numbers, scaffolds were washed with 1X PBS for 10 minutes twice 
and then soaked in urothelial cell medium for 4 hours prior to cell seeding. A total of 5 x 105 cells were 
seeded on the BMC surface of each treatment group in triplicate. Scaffolds were then placed in an 
incubator at 37°C in 5% CO2 for 14 days of culture.  Culture media was replaced on days 2, 5, 7, 10 and 
12. After 7 days and 14 days of culture, cell-seeded scaffolds were fixed in a solution of 4% 
paraformaldehyde (PFA) in PBS for 30 minutes.  
 
2.8 F-Actin staining and immunolabelling of cell-seeded scaffolds  
The fixed 2 cm diameter scaffolds from each treatment group were cut into quarters with surgical 
scissors and either stained for F-Actin, immunolabelled for E-cadherin or used for apoptosis analysis. 
Scaffold quarters were washed with 1X PBS prior to permeabilization with 1X PBST (1x PBS with 0.1% 
Tween and 0.19% Triton) for 10 minutes. Blocking solution (5% goat serum and 1% BSA in PBST) was 
applied for 30 minutes at room temperature. To visualize the F-actin cytoskeleton, Alexa Fluor® 488 
phalloidin (Invitrogen, A12379, 1:40) was added to each scaffold segment for 20 minutes at room 
temperature. Scaffolds were washed with 1X PBS three times for 5 min each. 4',6-diamidino-2-
phenylindole (DAPI) was used as a nuclear counterstain. Images were taken with a Zeiss Axiovert 
microscope capturing z-stacks of approximately 20-30 images. An extended focus filter was used to 
flatten the image and remove out of focus light scattering; images were captured from four random 
fields across each scaffold. 
 
For E-cadherin immunolabelling the primary antibodies, diluted in blocking solution, were added to 
scaffold quarters for 16 h at 4°C in a humidified chamber. The slides were then washed three times in 
PBS prior to the addition of the secondary antibody for 1 h in a humidified chamber at room 
temperature. DAPI was used as a nuclear counterstain. The primary antibody used was rabbit anti-E-
cadherin (Abcam, AB15148. 1:50). The secondary antibody used was Alexa Fluor® goat anti-rabbit 488 
(Invitrogen, A11008, 1:400). All primary antibodies were confirmed to cross-react with human 
epitopes. Scaffold quarters were mounted on coverslips with Prolong® Gold antifade mounting 
medium (Invitrogen, P36930). Images were taken with a Zeiss Axiovert microscope capturing z-stacks 
of approximately 20-30 images. An extended focus filter was used to flatten the image and remove 
out of focus light scattering; images were captured from four random fields across each scaffold.  
 
Determination of apoptosis of HUCs on the BMC was conducted by Click-iT® Plus TUNEL assay for in 
situ apoptosis detection with Alexa Fluor® dyes (Molecular probes, C10617, C10618, C10619) 
according to the manufacturer’s specifications. Images were taken with a Zeiss Axiovert microscope 
capturing four random fields across the scaffold. 
 
2.9 Transepithelial electrical resistance measurements  
UBM sheets from each group were cut to 8 mm diameter circles, placed into transwell inserts 
(Corning™ BioCoat™ Assay System, 1.0um membrane) with BMC luminal surface facing upwards and 
sterilized in situ with ETO gas (16 h cycle at 50 °C in a Series 3plus EOGas Sterilizer, Anderson Sterilizers, 
Inc., Haw River, NC). For transepithelial electrical resistance measurements Caco-2 cells (passages 24-
28, ATCC® HTB-37™) were cultured to approximately 80% confluence in MEM containing non-essential 
amino acids, 1mM sodium pyruvate, and 20% FBS. Caco-2 cells were seeded on the BMC luminal 
surface and the functional response was evaluated using a rapid differentiation system (Corning™ 
Biocoat™ HTS Caco-2 Assay) per manufacturer’s instructions. The functional response was measured 
by transepithelial electrical resistance (TEER). TEER of Caco-2 monolayers was measured with an 
Epithelial Voltohmmeter (EVOM2, World Precision Instruments). Electrical resistance of each scaffold 
type without cells was also measured and subtracted from the total electrical resistance determined 
with the monolayer to calculate the TEER of the monolayer. 
 
2.10 Statistical analysis  
ToF-SIMS data shown in PCA scores plots show 95% multivariate confidence intervals. Peak intensity 
plots show mean (bar), 25th and 75th quartiles (box) with whiskers extending 1.5 interquartile ranges 
(IQR) beyond them. All other data (apoptosis and TEER) are reported as mean and standard error.  
 3. RESULTS  
3.1 Decellularization efficacy    
Imaging of the H&E stained sections showed a reduction in visible nuclei with sodium deoxycholate 
and 1% SDS treatment (Supplementary Figure 1). Double-stranded DNA quantification of the scaffolds 
showed that with the exception of CHAPS, each detergent caused markedly greater removal of the 
dsDNA compared with treatment by dH2O or PAA (Supplementary Figure 1A). Scaffolds treated with 
1% SDS contained less dsDNA than those treated by any other detergent (p < 0.05).  
 
3.2 Detergent treatments produced structural differences in UBM  
Scanning electron micrographs showed morphological and structural differences between the UBM 
scaffolds treated with different detergents. Scaffolds treated with water, 3% Triton X-100 or 4% 
sodium deoxycholate retained an intricate fibre network (Fig. 1A, C and E) as previously observed [45]. 
Treatment with PAA and 1% SDS produced an amorphous structure lacking distinct fibres (Fig. 1B and 
G) whilst treatment with 8 mM CHAPS and 0.1% SDS resulted in a mix of amorphous characteristics 
with some retained fibre networks.  
 
3.3 Residual detergent fragments are detected by ToF-SIMS  
Representative negative ion spectra of UBM scaffolds treated with different detergents are shown in 
Figure 2. Spectral differences between treatment groups were apparent but also included an intense 
peak at m/z 79 in native tissue which appeared at low intensities in all treatment groups. Additionally, 
a notable pair of peaks at m/z 265 and m/z 293 occurred in the spectra of SDS treated UBM; these 
were not seen in other detergent treatments. Other differences in the spectra were observed but the 
importance of individual peaks was difficult to assess visually due to the diminishing intensity of peaks 
at increasing mass.  
 
Principal component analysis (PCA) aids in the identification of peaks characteristic of spectral 
difference between treatment groups by rotation of the dataset into new variables (principal 
components) that sequentially describe those with the most variance between treatment groups. 
Each principal component (PC) is associated with two plots: a scores plot, which describes difference 
between treatment groups and a loading plot, which describes the contribution of peaks to the PC.  
The signs of scores and loadings are linked; a sample with negative scores is associated with peaks 
which have negative loadings. 
 
Scores and loadings plots for the first two principal components of PCA of the negative ion spectra 
(Fig. 2) are provided in Figure 3. The first principal component (PC1) described 47.6% of the variance 
in the dataset. UBM scaffolds treated with water, PAA and CHAPS had negative scores which were 
associated with strongly negatively loading peaks at m/z 63 and 79. These peaks were indicative of 
phosphate fragments: m/z 63 (PO2-) and 79 (PO3-). Native (water treated) scaffolds showed the most 
negative score, followed by PAA and then CHAPS treated samples. All other treatment groups showed 
positive loadings. PC2 described 25.9% of the variance in the data set. Scaffolds treated with Triton X-
100, CHAPS and sodium deoxycholate had negative scores, associated with low mass peaks with 
strong negative loads including m/z 16, 26 and 42. These peaks were assigned to (O-), (CN-) and (CNO-
) respectively. A peak at m/z 391.3 also had a negative loading and this could be assigned as the 
deprotonated molecular ion of deoxycholate (C24H39O4-). 
 
Samples treated with both concentrations (0.1 and 1.0 %) of SDS showed positive scores; a larger 
variance in score occurred with 0.1% SDS treatment. These scores were associated with a range of 
positively loaded peaks, which included lower mass fragments such as phosphate fragments at m/z 
79 (PO3-) and m/z 110 (CH3PO4) and sulphate fragments at m/z 80 (SO3-), m/z 96 (SO4-) and m/z 97 (SO4 
+H)-. Several higher mass peaks also had strong positive loads in PC2. The peak at m/z 265 could be 
assigned to the SDS molecular ion (C12H25SO4-), while that at m/z 293 is likely the molecular ion of 
sodium tetradecyl sulphate (C14H29SO4-), a common contaminant of SDS [51]. Further principal 
components of the negative ion spectra did not provide significant separation between treatment 
groups as can be seen in the scores and loadings plot of PC3, Supplementary Figure 2.  
 
The intensities of residual detergent fragments from sodium deoxycholate, Triton X-100 and SDS are 
shown in Figure 4; details of the polarity and assignment are provided in Table 1. Analysis of dried 
detergent spots enabled the identification of the deprotonated deoxycholate molecular ion (C24H39O4-
) at m/z 391.3. This ion was noticeably more intense in the negative ion spectra of UBM treated with 
deoxycholate (Fig. 4A) compared to any other treatment group. There was considerable variation in 
the intensity within individual spectra recorded for deoxycholate treated UBM with two outlying 
points exhibiting three times the mean intensity. These spectra were obtained from the same sample, 
suggesting that variance within a sample was more significant than spot-to-spot variance on different 
samples (Fig. 4A).  
 
Analysis of dried detergent spectra (Supplementary Figs. 3 – 5) enabled the identification of the 
deprotonated molecular ion of Triton X-100 (C14H21O-) at m/z 205.2. There was a greater intensity of 
this ion in the negative spectra of UBM treated with Triton X-100, compared to other treatment groups 
(Fig. 4B).  
 
Figures 4C and 4D show the intensity of (SO4-) at m/z 79 and (C12H25SO4-) at m/z 265. These fragments 
were identified as the sulphate head group of SDS and the SDS molecular ion. Both fragments were 
uniquely characteristic of SDS in PCA of dried detergent spots (Supplementary Fig. 5) and contributed 
to the separation of SDS treated UBM samples from other treatment groups in PC2 of PCA of negative 
ion spectra of UBM (Fig. 3). Intensity of the sulphate head group was low in Triton X-100 and 
deoxycholate treated UBM. However there appeared to be some intensity of the (SO4-) in UBM treated 
with water, PAA and CHAPS (Fig. 4C). The SDS molecular ion occurred at high intensities in UBM 
treated with 1% SDS and at much lower intensities in UBM treated with a lower concentration of SDS, 
0.1 %.  
 
Representative positive ion spectra of UBM scaffolds treated with different detergents are shown in 
Supplementary Figure 6. The scores and loadings plots for principal component 1 (PC1) from the 
positive ion spectra are provided in Figure 5; PC1 described 80.3% of the variance in the dataset and 
separated water and PAA treated samples, with positive scores, from the other treatment groups, 
which all scored negatively. Deoxycholate and 1% SDS treated samples showed tighter confidence 
intervals compared to the other negatively scoring treatment groups: Triton X, CHAPS and 0.1% SDS. 
Several notable positive loading peaks were associated with phospholipid fragments which included 
the phospholipid head group (C5H15NPO4+) at m/z 184.1 and other associated fragments at m/z 104.1 
(C5H14NO+) and m/z 224.1(C9H19PO4+). Further principal components of the positive ion spectra did not 
provide significant separation between treatment groups as can be seen in the scores and loadings 
plot of PC2, Supplementary Figure 7. 
 
3.4 Residual nuclear and cell membrane fragments are detected by ToF-SIMS  
The intensity of fragments associated with cell membrane and nuclear associated mass peaks are 
shown in Figure 6; polarity and assignment details are provided in Table 1. Figure 6A shows the 
intensity of (PO3-) at m/z 78.96, a phosphate peak associated with both phospholipids from cell 
membranes and the phosphate groups in DNA. Figure 6B shows the intensity of a phosphocholine 
fragment (C5H15NPO4+) at m/z 184.12, associated with cell membrane. High intensity of the phosphate 
and phosphocholine peaks was seen in native (water) and PAA treated UBM and a lower intensity was 
observed in CHAPS treated UBM. Samples treated with Triton X-100, sodium deoxycholate and 1% 
SDS show considerably lower intensities, over 90% lower than that observed with water treated UBM. 
Both the phosphate and phosphocholine peaks were more intense in samples treated with 0.1% 
compared to 1% SDS. The phosphate group had a lower intensity in PAA compared to the 
phosphocholine head group. Other phosphocholine fragments including choline (C5H14NO+) at m/z 
104.1 and glycerophosphocholine (C9H19NPO4+) at m/z 224.1 were identifiable in UBM spectra; these 
fragments showed similar differences in intensity between treatment groups.  
 
3.5 Surface molecular functionality affects cell behaviour  
Human urothelial cells (HUC) cultured on the surface of Triton X-100, CHAPS and sodium deoxycholate 
treated bladders had similar levels of confluence and phenotypic morphology compared to cells 
cultured on scaffolds treated with deionized water (Fig. 7A).  HUC cultured on PAA treated bladders 
were less confluent with a more rounded morphology (Fig. 7B) compared to deionized water treated 
scaffolds (Fig. 7A).  HUC cultured on bladders treated with SDS had fragmented nuclei and poor 
morphology and there was reduced cell confluence on SDS treated bladders compared to all other 
treatment groups (Supplementary Fig. 8A). HUC morphology and confluence worsened with 
increasing SDS concentrations (Fig. 7F and Fig. 7G) with the highest percentage of apoptotic cells on 
1% SDS treated scaffolds (Supplementary Fig. 8A). Additionally, TEER values of Caco-2 cells seeded 
onto treated bladders showed a lower TEER for SDS treated bladders with increased SDS concentration 
having a greater effect upon the TEER (Supplementary Fig. 8C).  
 
Although similar levels of confluence and phenotype of HUC were observed with Triton X-100, CHAPS 
and sodium deoxycholate treated bladders compared to deionized water treatment, tight junction 
formation of HUC occurred only when HUC were cultured on deionized water treated bladders 
(Supplementary Fig. 9).  
 
4. DISCUSSION 
An acceptable balance must be maintained between using detergents to remove cellular materials 
and detergent mediated ECM disruption. Ineffective decellularization can induce a strong 
inflammatory response [44] but excessive damage to ECM ultrastructure, growth factors and critical 
ECM components can adversely affect cytocompatibility and the ability to facilitate functional tissue 
replacement.  Non-ionic detergents are effective in cell removal from thin tissues and cause less 
disruption of ultrastructure and less glycosaminoglycan [52] removal compared to ionic detergents 
[45, 53]. Ionic detergents are effective in removing nuclear remnants and cytoplasmic proteins from 
dense tissues but also remove growth factors and GAGs and have been shown to damage collagen 
and vimentin [54]. Some zwitterionic detergents such as sulfobetaine-10 (SB-10) and sulfobetaine-16 
(SB-16) have shown greater ECM preservation and better cell removal than non-ionic detergents [55]; 
however a recent study showed that the basement membrane integrity of bladders was disrupted 
similarly by CHAPS or 1% SDS treatment [45].  
 
Although the deleterious effects of detergents upon structure and composition are well-characterized, 
there is a paucity of information concerning detergent impact upon the functionality of biologic 
scaffolds. Host remodeling of a biologic scaffold is driven by the initial response of the host cells to the 
implanted material. The surface topography and ligand landscape of the material will determine the 
host molecules that are adsorbed to the surface and thus influence subsequent cell behaviour. A 
comprehensive understanding of the impact of detergents upon surface characteristics is essential for 
development of successful in vivo recellularization strategies and host remodeling of scaffolds and 
whole organ constructs.  
 
There are currently no regulatory requirements for decellularization which was one of the motivations 
for the present study.  We strongly believe that ‘thorough’ decellularization is critical for downstream 
clinical outcomes. Previously we have suggested guidelines for decellularization [30] and published 
papers on the effects of inadequate decellularization [44]. The study attempts to show the effects of 
commonly used decellularization agents and bring awareness to the importance of this critical 
manufacturing step for biologic scaffold materials. 
 
Detergent treatment of UBM samples produced marked changes in fibre network. Only scaffolds 
treated with Triton X-100 or sodium deoxycholate retained the intricate fibre network present in 
native UBM samples (Fig. 1).  Treatment with CHAPS, SDS and PAA altered collagen fibre organization, 
with 1% SDS and PAA producing amorphous structures lacking distinct fibres. These changes in the 
topography of UBM samples added additional complexity to the use of ToF-SIMS to identify 
compositional differences in detergent decellularized scaffolds. Nonetheless, ToF-SIMS analysis 
detected residual detergent fragments in UBM scaffolds treated with sodium deoxycholate, SDS and 
Triton X-100 (Fig. 4). UBM samples treated with either deoxycholate or Triton X-100 showed greater 
intensity of the respective deprotonated molecular ions compared to other treatments. A sulphate 
head group, characteristic of SDS treatment was observed in SDS samples. Although there was low 
intensity in Triton X-100 and sodium deoxycholate samples, some intensity was observed in water, 
PAA and CHAPS treated bladders but this was likely due to a peak overlap with the phosphate 
fragment present in these treatment groups. Intensity of the SDS molecular ion clearly separated SDS 
treated UBM sample from all other treatments; a concentration dependent intensity increase was 
observed. Evidence of residual CHAPS was not identified in CHAPS treated UBM. Its charge-neutral 
form may facilitate removal through washing. Additionally CHAPS appeared to be highly susceptible 
to fragmentation; low mass fragments under m/z 200 dominated the positive ion spectra 
(Supplementary Fig. 4) as can be seen in the negative loadings of PC2 (Supplementary Fig. 5A).  
 
In conjunction with ToF-SIMS detection of detergent fragments, this study demonstrated the 
applicability of ToF-SIMS to detect cell nuclei and cell membrane fragments in biologic scaffolds. ToF-
SIMS analysis showed the presence of choline, phosphocholine and glycerophosphocholine ions, 
which have key roles in the structural integrity of cell membranes in native, PAA and CHAPS treated 
UBM. Higher intensity of the choline related fragments was observed in water and PAA treated UBM 
compared to CHAPS (Fig. 6B). Additionally, two phosphate groups, characteristic of cell nuclei, had 
higher intensities in PAA, CHAPS and water treated UBM, compared to Triton X-100, sodium 
deoxycholate and SDS treated UBM (Fig. 6A). PAA treated UBM had less intensity of the phosphate 
group compared to native tissue whereas the intensity of the phosphocholine was similar in both 
native and PAA treated UBM. This indicates that PAA was more effective in removing cell nuclear 
material rather than cell membrane components; PAA has previously been shown to be effective in 
disassociation of DNA from cell nuclei [44]. Since the phosphate and phosphocholine ions are 
indicative of residual cell debris, the presence of these ions facilitates assessment of decellularization 
efficacy. Notably, the residual cellular components observed in PAA and CHAPS treated bladders show 
that these methods of treatment were ineffective at completely removing cellular material from the 
UBM samples. The most effective removal of cellular material was achieved with 1% SDS and 
deoxycholate treatment, which was expected given that ionic detergents are effective in removing 
nuclear remnants [54]. The lower concentration of SDS (0.1%) and non-ionic Triton X-100 had low 
levels of intensity of the phosphate and phosphocholine ions, indicating that these treatments were 
not as effective as the higher concentration ionic detergents.  
 
To complement ToF-SIMS analysis, the influence of detergent treatment upon in vitro cell behaviour 
was also examined. Structurally, the mammalian bladder is a hollow sphere with the innermost layers 
consisting of the tunica lamina propria and basement membrane lined with the urothelium, a layer of 
epithelial cells [56]. The urothelium is an example of transitional epithelium and is primarily 
responsible for providing the permeability barrier in the bladder. Cells are interconnected by tight 
junctional complexes which restrict paracellular ion support and limit diffusion of proteins [57]. 
Human urothelial cells in culture acquire a proliferative, regenerative phenotype, which can be 
manipulated by modification of the culture environment [58]. Previous studies have shown that 
differentiated urothelial tissues can be generated from normal human urothelial cells propagated in 
vitro [57, 59, 60]. Culture of human urothelial cells upon UBM scaffolds thus provided an ideal 
opportunity to assess the in vitro response of suitable host cells to the surface topography and ligand 
landscape of detergent treated urinary bladders. Viability, proliferative capacity and phenotype of 
HUC were maintained on UBM scaffolds treated with Triton X-100, CHAPS and sodium deoxycholate 
and was similar to cells cultured on scaffolds treated with deionized water (Fig. 7A). A previous 
investigation showed that CHAPS and SDS treatment resulted in a basement membrane complex with 
altered ultrastructure and composition; endothelial cells seeded on CHAPS and SDS treated scaffolds 
had reduced confluence [45]. In this study, HUC seeded on CHAPS treated bladders maintained 
confluence and phenotype whereas HUC seeded on bladders treated with PAA were less confluent 
and had a more rounded morphology. Peracetic acid is commonly used to disinfect post decellularized 
tissues but can also act as a decellularizing agent by removing nucleic acids [30]. Recent work utilizing 
PAA in the generation of tubular small intestinal submucosa (SIS) scaffolds showed that PAA was not 
effective at decellularization with a 2 hr treatment and that metabolic activity of primary human 
smooth muscle esophageal cells was much lower on PAA treated SIS compared to untreated SIS [61]; 
similar conclusions can be drawn from the present study.  
 
HUC cultured on SDS treated bladders had atypical morphology, fragmented nuclei and considerably 
reduced confluence compared to all other treatment groups. Increasing SDS concentration 
exacerbated problems with poor cellular morphology and confluence. SDS is an effective 
decellularization agent and has found application in the decellularization of many tissues and whole 
organs including tendon [15], lung [62] [63], aorta [64], pulmonary valves [23], kidney [65, 66], liver 
[67] and recently, retina [68]. However, many studies report deleterious effects of SDS upon ECM 
ultrastructure [45, 64, 69-72] including reduced collagen, elastin, glycosoaminoglycan (GAG) and 
growth factor content [45, 67, 73]. Alterations in the structural composition of ECM during 
decellularization can affect cell attachment, differentiation and function; poor cellular health and 
reduced functionality have been attributed to matrix alterations caused by SDS decellularization [61, 
67, 72]. With the notable exception of Rieder et al [74], who showed residual SDS caused massive cell 
lysis during recellularization, the effect of residual SDS upon cell repopulation has been considered 
insignificant [23, 72]. Nonetheless, ToF-SIMS detection of SDS fragments in this work indicates that 
cellular responses may be a result of residual SDS coupled with adverse effects upon the biochemical 
composition and topographical ligand landscape.  
 
Previous studies have shown that HUC can form stratified cell layers exhibiting tight junctions between 
cells when cultured in calcium supplemented medium [57] or upon deepithelialized stroma [60]. In 
this study, HUC maintained viability and phenotype when cultured upon Triton X-100, CHAPS and 
sodium deoxycholate treated UBM. However, localised intercellular border E-cadherin staining 
evident of stratification and the formation of tight junctional complexes was only observed when HUC 
were cultured on deionized water treated bladders. All detergent treatments appeared to affect the 
ability of HUC to form stratified cell layers in vitro.  
 
5. CONCLUSIONS 
ToF-SIMS analysis was used to identify differences in the composition of urinary bladder matrix, a 
representative biologic scaffold, exposed to detergents; surface molecular functionality was 
correlated with in vitro cell behaviour. ToF-SIMS analysis, providing high analytical sensitivity 
molecular specificity and surface localization, showed that Triton X-100, sodium deoxycholate and SDS 
residual fragments remained after detergent treatment of UBM. It is likely that residual SDS 
fragments, alongside matrix alterations, contributed to atypical phenotype, lower viability and 
reduced confluence of human urothelial cells cultured upon SDS treated UBM. Increased SDS 
concentrations, from 0.1% to 1.0%, increased both the intensity of residual SDS fragments and adverse 
cell outcomes. ToF-SIMS analysis detected cellular remnants, attributed to nuclear and membrane 
material, in PAA and CHAPS treated UBM. Detection of the phosphate and phosphocholine ions 
facilitates assessment of decellularization efficacy; PAA and CHAPS treatment were ineffective at 
completely removing cellular material from the UBM samples. This study demonstrates the 
importance of maintaining a balance between cell removal and detergent disruption of matrix 
architecture and matrix surface ligand landscape.  This study also demonstrates the power of ToF-
SIMS for the characterization of decellularized scaffolds and, considering the importance of 
decellularized bioscaffolds for clinical tissue reconstruction, justifies further studies to achieve the 
optimum balance between thorough decellularization, maintenance of ECM ultrastructure and 
biologic functionality. 
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 FIGURES & TABLES  
 
Figure 1: SEM of the BMC fibre network of UBM samples prepared with (A) water as a no-detergent 
control, (B) PAA, (C) Triton X-100, (D) CHAPS, (E) sodium deoxycholate, (F) SDS (0.1%) and (G) SDS 
(1.0%); scale bar represents 1 μm.  
 
 Figure 2: Representative negative ion spectra of native porcine urinary bladders and bladders treated 
with  PAA, Triton X-100, CHAPS, sodium deoxycholate and SDS (1.0%).    
 
 Figure 3: Principal component analysis (PCA) of negative ion spectra of UBM samples. Scores (left) and 
loadings (right) plots are shown for the first (top) and second (bottom) principal components which 
describe 47.6% and 25.9% of variance respectively. In the scores plots, bars represent mean and 95% 
confidence intervals. In the loadings plots, prominent highly-loading peaks are marked and labelled.  
 
  
 Figure 4: Peak intensities of residual sodium deoxycholate (A), Triton X-100 (B) and SDS fragments (C) 
and (D).  All data points are shown. Overlaid box plots show mean (bar), 25th and 75th quartiles (box) 
with whiskers extending 1.5 IQR beyond them. 
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Figure 5: Principal component analysis (PCA) of positive ion spectra of UBM samples. Scores (left) and 
loadings (right) plots are shown for the first principal component which described 80.3% of variance. 
In the scores plot, bars represent mean and 95% confidence intervals. In the loadings plot, prominent 
highly-loading peaks are marked and labelled. 
 
 
Figure 6:  Peak intensities of cell nuclear (A) and cell membrane (B) associated compounds. All data 
points are shown. Overlaid box plots show mean (bar), 25th and 75th quartiles (box) with whiskers 
extending 1.5 IQR beyond them. 
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Figure 7: F-actin cytoskeleton of human urothelial cells cultured on the BMC of porcine urinary 
bladders prepared with (A) water, (B) PAA, (C) Triton X-100, (D) CHAPS, (E) sodium deoxycholate, (F) 
SDS (0.1%) and (G) SDS (1.0%); scale bar represents 100 μm. 
 
Table 1: Summary of the polarity, mass, assignment, identity and association of highly loading peaks 
seen in PCA loadings plots shown in Figures 4 and 6. 
 
Polarity m/z Assignment Identity Association PC 
Negative 63.0 PO2- Phosphate Residual nuclear 
material 
1 
Negative 79.0 PO3- Phosphate 1 
Positive 184.1 C5H15NPO4+ Phosphocholine Residual cell 
membrane 
1 
Positive 224.1 C9H19NPO4+ Glycerophosphocholine 1 
Positive 104.1 C5H14NO+ Choline 1 
Negative 80.0 SO3- Sulphate SDS headgroup 2 
Negative 97.0 SO4- 2 
Negative 265.1 C12H25SO4- Dodecylsulphate SDS 2 
Negative 293.1 C12H25O2Na4- SDS micelle SDS 2 
Negative 391.3 C24H49O4 Deprotonated 
deoxycholate 
molecular ion 
Deoxycholate 2 
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Supplementary Figure 1: Double-stranded DNA quantification of the scaffolds treated with 3% Triton 
X-100, 4% sodium deoxycholate and 0.1% and 1% SDS showed significant removal compared with 
those treated with deionised water (A). H&E stained sections of scaffolds prepared with (B) no 
detergent (deionised water only), (C) PAA, (D) Triton X-100, (E) CHAPS, (F) sodium deoxycholate,  (G) 
0.1% SDS and (H) 1% SDS.  Scale bar represents 20 μm. 
 
 
 
 
 
Supplementary Figure 2: PCA of negative ion spectra of UBM samples, with scores (left) and loadings 
(right) plots shown for the principal component 3. In the scores plots, bars represent mean and 95% 
confidence intervals. In the loadings plots, prominent highly-loading peaks are marked and labelled. 
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Supplementary Figure 3: Representative positive ion spectra of (A) CHAPS, (B) Triton X-100, (C) SDS 
(1.0 %) and (D) sodium deoxycholate dried onto silicon wafers.  
 
Supplementary Figure 4: Representative negative ion spectra of (A) CHAPS, (B) Triton X-100, (C) SDS 
(1.0 %) and (D) sodium deoxycholate dried onto silicon wafers. 
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Supplementary Figure 5: PCA of positive ion spectra (A) and negative ion spectra (B) for detergent 
treatments on silicon wafers.  
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Supplementary Figure 6: Representative positive ion spectra of (A) native porcine urinary bladders and 
bladders treated with (B) PAA, (C) Triton-X, (D) CHAPS, (E) sodium deoxycholate, (F) SDS (0.1%) and 
(G) SDS (1.0%).   
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Supplementary Figure 7: PCA of positive ion spectra of UBM samples, with scores (left) and loadings 
(right) plots shown for the principal component 2. In the scores plots, bars represent mean and 95% 
confidence intervals. In the loadings plots, prominent highly-loading peaks are marked and labelled. 
 
 
 
 
Supplementary Figure 8: Quantification of HUC morphology and behaviour upon detergent treated 
scaffolds showed (A) reduced ability of SDS-treated samples to support cell growth whether 1% 
(p=0.0029) or 0.1% (p=0.004). (B) Apoptosis followed similar trend with cells grown on 1% SDS-treated 
samples showing the highest percentage of TUNEL staining. (C) The functional response measured via 
TEER values of Caco2 cells was similar for the water, Triton X-100, and CHAPS groups while the 
Deoxycholate, 1% and 0.1% SDS all resulted in lowered TEER values relative to the water only control.  
 
 
 
0
20
40
60
80
100
N
u
m
b
e
r 
o
f 
C
e
ll
s
 p
e
r 
H
ig
h
 
P
o
w
e
r 
F
ie
ld
0%
20%
40%
60%
80%
100%
P
e
rc
e
n
t 
(%
) 
T
U
N
E
L
 P
o
s
it
iv
e
 
c
e
ll
s*
*
0%
20%
40%
60%
80%
100%
P
e
rc
e
n
t 
(%
) 
In
c
re
a
s
e
 i
n
 
T
E
E
R
 R
e
la
ti
v
e
 t
o
 S
c
a
ff
o
ld
 
O
n
ly
 C
o
n
tr
o
l
A B
C
  
 
Supplementary Figure 9: Tight junction formation of human urothelial cells cultured on the BMC of 
porcine urinary bladders prepared with water; scale bar represents 100 μm. 
